Ventas (NYSE:VTR) Price Target Raised to $100.00 at Citigroup

Key Points

• Citigroup raised its price target on Ventas to $100 (from $96) and kept a "buy" rating, implying roughly a 13.5% upside from the prior close.
• Ventas reported Q1 EPS $0.11 (missed by $0.01) while revenue was $1.65B (beat estimates) and rose 22% YoY; the company set FY2026 EPS guidance of 3.820–3.890, roughly in line with analyst expectations (~3.85).
• Top executives sold stock (CEO and EVP transactions), leaving insider ownership at ~0.53% while institutional investors own ~94.18%; the shares trade near their 52‑week high (~$88.11) with a market cap of about $41.9B.

Ventas (NYSE:VTR - Get Free Report) had its price objective upped by investment analysts at Citigroup from $96.00 to $100.00 in a research note issued on Friday,Benzinga reports. The firm presently has a "buy" rating on the real estate investment trust's stock. Citigroup's price target points to a potential upside of 13.50% from the company's previous close.

A number of other research analysts have also commented on the company. KeyCorp upped their target price on Ventas from $85.00 to $90.00 and gave the company an "overweight" rating in a research note on Tuesday, February 10th. Weiss Ratings restated a "buy (b-)" rating on shares of Ventas in a research note on Friday, March 27th. Argus set a $88.00 target price on Ventas in a research note on Tuesday, February 10th. JPMorgan Chase & Co. upped their target price on Ventas from $88.00 to $93.00 and gave the company an "overweight" rating in a research note on Friday, March 20th. Finally, Morgan Stanley set a $90.00 target price on Ventas in a research note on Friday, February 13th. Thirteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, Ventas has a consensus rating of "Moderate Buy" and a consensus target price of $91.73.

Ventas Stock Performance

Shares of VTR stock traded up $0.25 during trading hours on Friday, reaching $88.11. 2,895,238 shares of the company's stock were exchanged, compared to its average volume of 3,360,939. The business has a fifty day moving average price of $84.79 and a 200-day moving average price of $80.03. The company has a quick ratio of 0.67, a current ratio of 0.25 and a debt-to-equity ratio of 0.95. The stock has a market capitalization of $41.89 billion, a P/E ratio of 160.20, a P/E/G ratio of 2.15 and a beta of 0.75. Ventas has a fifty-two week low of $61.76 and a fifty-two week high of $88.41.

Ventas (NYSE:VTR - Get Free Report) last issued its earnings results on Monday, April 27th. The real estate investment trust reported $0.11 EPS for the quarter, missing analysts' consensus estimates of $0.12 by ($0.01). The firm had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.59 billion. Ventas had a net margin of 4.25% and a return on equity of 2.09%. The business's revenue for the quarter was up 22.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.84 earnings per share. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Analysts predict that Ventas will post 3.85 EPS for the current fiscal year.

Insiders Place Their Bets

In other Ventas news, CEO Debra A. Cafaro sold 10,322 shares of the company's stock in a transaction on Monday, February 2nd. The stock was sold at an average price of $77.66, for a total value of $801,606.52. Following the sale, the chief executive officer directly owned 1,114,034 shares in the company, valued at $86,515,880.44. This represents a 0.92% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Carey S. Roberts sold 35,532 shares of the company's stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $85.00, for a total value of $3,020,220.00. Following the completion of the sale, the executive vice president owned 72,755 shares in the company, valued at $6,184,175. This trade represents a 32.81% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.53% of the company's stock.

Institutional Trading of Ventas

Several large investors have recently made changes to their positions in VTR. NewEdge Advisors LLC grew its holdings in shares of Ventas by 856.1% during the first quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust's stock worth $545,000 after purchasing an additional 7,097 shares during the last quarter. Empowered Funds LLC grew its holdings in shares of Ventas by 6.8% during the first quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust's stock worth $576,000 after purchasing an additional 536 shares during the last quarter. Woodline Partners LP grew its holdings in shares of Ventas by 46.8% during the first quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust's stock worth $2,532,000 after purchasing an additional 11,739 shares during the last quarter. Focus Partners Wealth grew its holdings in shares of Ventas by 130.4% during the first quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust's stock worth $1,486,000 after purchasing an additional 12,233 shares during the last quarter. Finally, Gamco Investors INC. ET AL bought a new stake in shares of Ventas during the second quarter worth $805,000. Institutional investors own 94.18% of the company's stock.

Ventas Company Profile

Ventas, Inc NYSE: VTR is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas' business model combines property ownership with active asset management and capital markets activity.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.